成人院外心脏骤停上肢骨内与静脉血管通路比较:VICTOR整群随机临床试验
VICTOR试验为整群随机对照试验,在台北市4个高级生命支持救护队中比较骨内与静脉通路对成人非创伤性院外心脏骤停的疗效。共纳入1771例,主要分析1732例(骨内组741例,静脉组991例)。骨内组出院存活79例(10.7%),静脉组102例(10.3%),OR 1.04(95%CI 0.76-1.42;P=0.81)。院前自主循环恢复、持续自主循环恢复及良好神经功能存活的OR均无统计学显著差异。
要点
- 成人非创伤性院外心脏骤停中,骨内组出院存活79/741(10.7%)vs 静脉组102/991(10.3%),OR 1.04(95%CI 0.76-1.42;P=0.81)。
- 院前自主循环恢复:骨内 vs 静脉 OR 1.23(95%CI 0.89-1.69;P=0.21),未达统计学显著。
- 持续自主循环恢复(≥2小时):骨内 vs 静脉 OR 0.92(95%CI 0.75-1.13;P=0.44),未达统计学显著。
- 出院时良好神经功能(脑功能分级≤2):骨内 vs 静脉 OR 1.17(95%CI 0.82-1.66;P=0.39),未达统计学显著。
- 结论:骨内通路初始尝试与静脉通路相比,出院存活、院前自主循环恢复、持续自主循环恢复及良好神经功能预后均无显著差异。
适用人群与场景
- 成人(年龄20-80岁)非创伤性院外心脏骤停患者。
- 场景:台北市4个高级生命支持救护队参与的院前急救。
- 入组时间:2020年7月6日至2023年6月30日,因COVID-19大流行于2021年5月20日至2021年7月31日暂停。
处置流程与药物剂量
- 每两周将4个参与的高级生命支持救护队随机整群分配至骨内或静脉通路插入。
研究设计与关键结果
- 研究类型:整群随机对照试验;纳入1771例,主要分析1732例(骨内组741例,静脉组991例);中位年龄65.0岁;男性1234例(71.2%)。
- 主要终点出院存活:骨内组79例(10.7%)vs 静脉组102例(10.3%),OR 1.04(95%CI 0.76-1.42;P=0.81)。
- 院前自主循环恢复:骨内 vs 静脉 OR 1.23(95%CI 0.89-1.69;P=0.21)。
- 持续自主循环恢复(≥2小时):骨内 vs 静脉 OR 0.92(95%CI 0.75-1.13;P=0.44)。
- 出院时良好神经功能(脑功能分级≤2):骨内 vs 静脉 OR 1.17(95%CI 0.82-1.66;P=0.39)。
证据类型、等级与局限
- 证据类型:整群随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:成人非创伤性院外心脏骤停中,骨内通路初始尝试与静脉通路相比,出院存活、院前自主循环恢复、持续自主循环恢复及良好神经功能预后均无显著差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To compare the effectiveness of intraosseous versus intravenous vascular access in the treatment of adult patients with out-of-hospital cardiac arrest.
DESIGN: Cluster randomised controlled trial.
SETTING: The VICTOR (Venous Injection Compared To intraOsseous injection during resuscitation of patients with out-of-hospital cardiac arrest) trial involved emergency medical service agencies with all four advanced life support ambulance teams in Taipei City, Taiwan. The enrolment period spanned 6 July 2020 to 30 June 2023 and was temporarily suspended between 20 May 2021 and 31 July 2021 owing to the covid-19 pandemic.
PARTICIPANTS: Adult (age 20-80 years) patients with non-traumatic out-of-hospital cardiac arrest.
INTERVENTIONS: Biweekly randomised clusters of four participating advanced life support ambulance teams were assigned to insert either intravenous or intraosseous access.
MAIN OUTCOME MEASURES: The primary outcome was survival to hospital discharge. Secondary outcomes included return of spontaneous circulation, sustained return of spontaneous circulation (≥2 hours), and survival with favourable neurological outcomes (cerebral performance category score ≤2) at hospital discharge.
RESULTS: Among 1771 enrolled patients, 1732 (741 in the intraosseous group and 991 in the intravenous group) were included in the primary analysis (median age 65.0 years; 1234 (71.2%) men). In the intraosseous group, 79 (10.7%) patients were discharged alive, compared with 102 (10.3%) patients in the intravenous group (odds ratio 1.04, 95% confidence interval 0.76 to 1.42; P=0.81). The odds ratio of intraosseous versus intravenous access was 1.23 (0.89 to 1.69; P=0.21) for pre-hospital return of spontaneous circulation, 0.92 (0.75 to 1.13; P=0.44) for sustained return of spontaneous circulation, and 1.17 (0.82 to 1.66; P=0.39) for survival with favourable neurological outcomes.
CONCLUSIONS: Among adults with non-traumatic out-of-hospital cardiac arrest, initial attempts to establish vascular access through the intraosseous route did not result in different outcomes compared with intravenous access in terms of the proportion of patients surviving to hospital discharge, pre-hospital return of spontaneous circulation, sustained return of spontaneous circulation, and favourable neurological outcomes.
TRIAL REGISTRATION: NCT04135547ClinicalTrials.gov NCT04135547.
参考来源
- Ko YC, Lin HY, Huang EP, et al. Intraosseous versus intravenous vascular access in upper extremity among adults with out-of-hospital cardiac arrest: cluster randomised clinical trial (VICTOR trial). BMJ. 2024. PMID: 39043416. doi:10.1136/bmj-2024-079878
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。